The treatment of neonatal isoimmune thrombocytopenia with intravenous immunoglobin (IgG i.v.)

Abstract

We present a report of the use of IgG i.v. to treat clinically manifest neonatal immune thrombocytopenia. The IgG i.v. was administered at a daily dosage of 0.4 g/kg body weight for 5 days. Treatment was started when the child was 3 days old and had a platelet count of 2×10⁹/l. Four days later the platelet count had risen to 200×10⁹/l. The diagnosis of immune thrombocytopenia was confirmed by platelet typing of the mother's and child's platelets and identification of anti-platelet antibodies in maternal serum.